Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease (DIACEA)

Vall d'Hebron University Hospital (HUVH)

Status: Completed

Conditions: Alzheimer´s Disease; Diabetes Mellitus Type 2

Treatments: Other: There is a retrospectiv observational study. No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT02501876

PR(AG)32/2015

Details and patient eligibility

About

In recent years, it has been observed that the type 2 diabetic patients (DM-2) have an increased risk of developing dementia, both vascular and Alzheimer's disease (AD). The term mild cognitive impairment (MCI) describes a transition state between normal cognitive function and dementia. The annual rate of conversion to dementia in MCI patients is around 15% in the general population, regardless of the presence or absence of diabetes. At present it is not possible to identify which patients with MCI are most likely to progress to AD. On this basis, the main objective of this study is to evaluate whether the presence of diabetes and or the presence of its related genes favors the conversion of MCI to AD.

Full description

In recent years, it has been observed that the type 2 diabetic patients (DM-2) have an increased risk of developing dementia, both vascular and Alzheimer's disease (AD). The term mild cognitive impairment (MCI) describes a transition state between normal cognitive function and dementia. The annual rate of conversion to dementia in MCI patients is around 15% in the general population, ie regardless of the presence or absence of diabetes. At present it is not possible to identify which patients with MCI are most likely to progress to AD. On this basis, the main objective of this study is to evaluate whether the presence of diabetes favors the conversion of MCI to AD. We propose a case-control study comparing a group of 110 diabetic patients and a group of 110 non-diabetic patients with MCI matched by age, sex and cardiovascular risk factors. The main objective is the conversion to AD between the groups and if DM-2 is an independent risk factor. The secondary objective is to investigate whether genetic mechanisms related both to AD and DM-2 are associated with the increased risk of AD in diabetic patients. We will analyze 10 genes simultaneously associated with an increased risk of diabetes and / or its complications and AD.

Enrollment: 202 patients

Sex: All

Ages: 65 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diagnosis of MCI using the NBACE neuropsychological tests battery.
• Age >65 years.
• At least two years follow-up.
• 110 subjects with type 2 diabetes
• 110 subjects without diabetes
• written informed consent.

Exclusion criteria

• patients with cerebrovascular disease (previous stroke, intracerebral lesions, etc.), including significant vascular load according to scale Fazekas (escor˃2)

Trial design

202 participants in 2 patient groups

T2D-MCI

Description:

110 MCI subjects with type 2 diabetes. There is a retrospectiv observational study. No intervention will be performed.

Treatment:

Other: There is a retrospectiv observational study. No intervention

nonT2D-MCI

Description:

110 MCI subjects without diabetes. There is a retrospectiv observational study. No intervention will be performed.

Treatment:

Other: There is a retrospectiv observational study. No intervention